Reportlinker Adds 2010 U.S. Type 2 Diabetes Patients' Choice: Awareness, Usage, and Preferences of Insulin Injection Pens

Mar 24, 2011, 07:10 ET from Reportlinker

NEW YORK, March 24, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

http://www.reportlinker.com/p0461649/2010-US-Type-2-Diabetes-Patients-Choice-Awareness-Usage-and-Preferences-of-Insulin-Injection-Pens.html

Type 2 diabetes is the most common form of diabetes. It is a chronic disease marked by high levels of glucose in the blood. Type 2 diabetes is most common in patients that are of 45 years or greater, have a high-density lipoprotein (HDL) cholesterol of less than 35 mg/dL or triglyceride level of greater than 250 mg/dL, and/or have high blood pressure. The primary goal to treat type 2 diabetes is diet and exercise. However, if diet and exercise does not help maintain normal glucose levels, physicians may prescribe medication.

Table of Contents

Chapter 1: Research Background and Objectives 5-7

Chapter 2: Method Details 8-10

Chapter 3: Executive Summary 11-17

Chapter 4: Awareness of Insulin Injection Pen Brands 18-20

Chapter 5: Usage of Insulin Injection Pens 21-28

Chapter 6: Preferred Features of Insulin Injection Pens 29-32

Chapter 7: Satisfaction with and Future Intentions toward Current Brand 33-43

Chapter 8: Overall Brand Performance 44-50

Appendix 51-54

About Frost & Sullivan 55-63

To order this report:

:

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg

Reportlinker

Email: nbo@reportlinker.com

US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker



RELATED LINKS

http://www.reportlinker.com